Stocks and Investing Stocks and Investing
Tue, January 4, 2022
Mon, January 3, 2022
Sun, January 2, 2022
Fri, December 31, 2021
Thu, December 30, 2021
Wed, December 29, 2021
Tue, December 28, 2021
Mon, December 27, 2021
Thu, December 23, 2021
Wed, December 22, 2021
Tue, December 21, 2021

Cory Kasimov Maintained (BIIB) at Hold with Decreased Target to $276 on, Dec 21st, 2021


Published on 2024-10-27 19:04:08 - WOPRAI, Cory Kasimov
  Print publication without navigation


Cory Kasimov of JP Morgan, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $324 to $276 on, Dec 21st, 2021.

Cory has made no other calls on BIIB in the last 4 months.



There are 15 other peers that have a rating on BIIB. Out of the 15 peers that are also analyzing BIIB, 6 agree with Cory's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mohit Bansal of "Wells Fargo" Initiated at Hold and Held Target at $250 on, Thursday, December 9th, 2021
  • Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $271 on, Monday, December 6th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, November 19th, 2021
  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $270 on, Tuesday, October 26th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021


These are the ratings of the 9 analyists that currently disagree with Cory


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $325 on, Monday, December 20th, 2021
  • Evan Seigerman of "BMO Capital" Initiated at Buy and Held Target at $315 on, Friday, November 19th, 2021
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $375 on, Thursday, October 21st, 2021
  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $386 on, Thursday, October 21st, 2021
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $390 on, Thursday, October 21st, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $440 on, Thursday, October 21st, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $442 on, Thursday, September 16th, 2021